Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physiologic Testosterone Replacement in Women With Hypopituitarism
NCT00144391Phase 4Completed
- Sponsor
- Charles Drew University of Medicine & Science
- Start
- Jul 2003
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Testosterone TEPI patch in panhypopituitarism (2 arms), sponsored by Charles Drew University of Medicine & Science. Primary endpoint: Fatigue Impact Scale at 6 months. Started Jul 2003; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
panhypopituitarism
Beyond the preview
Go deeper on NCT00144391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00144391.